Skip to content

Ikarian Capital, LLC

Follow

13F filer, CIK 1778253, DALLAS, TX

Ikarian Capital, LLC reported $994,154,406 across 172 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 41.04% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002881

Period
2026-09-30
Reported value
$994M
Holdings
172
Top 10 weight
41.04%
New
49
Sold out
33

Part of the filer group Ikarian Capital, LLC

  • Neil Shahrestani
How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AMLXadded+443,959$12.9M
ORICnew+522,765$7.04M
PHVSadded+193,516$6.14M
RCUSadded+230,000$5.94M
DMRAnew+275,710$5.87M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KODreduced-526,617-$49.9M
PRAXreduced-65,900-$19.2M
ANIPreduced-123,020-$8.94M
DMRAexited-335,710-$8.73M
BHVNreduced-615,000-$8.21M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002881, largest first. % of portfolio is the value over $504,115,491, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 576,166 shares; 2025Q1: 649,534 shares; 2025Q2: 599,534 shares; 2025Q3: 413,841 shares; 2025Q4: 719,787 shares; 2026Q1: 1,265,795 shares; 2026Q2: 1,059,730 shares; 2026Q3: 533,113 shares 533,113$50.5M10.03%-526,617Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 396,098 shares; 2025Q4: 205,985 shares; 2026Q1: 57,635 shares; 2026Q2: 328,635 shares; 2026Q3: 285,909 shares 285,909$28.4M5.64%-42,726Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 200,000 shares; 2025Q2: 305,000 shares; 2025Q3: 311,682 shares; 2025Q4: 378,682 shares; 2026Q1: 428,682 shares; 2026Q2: 388,682 shares; 2026Q3: 400,465 shares 400,465$22.8M4.52%+11,783Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 378,363 shares; 2025Q1: 163,363 shares; 2025Q2: 163,363 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 504,559 shares; 2026Q3: 734,559 shares 734,559$19M3.76%+230,000Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 461,247 shares; 2026Q2: 478,500 shares; 2026Q3: 518,500 shares 518,500$16.8M3.33%+40,000Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 201,187 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 117,500 shares; 2026Q3: 561,459 shares 561,459$16.3M3.24%+443,959Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 210,165 shares; 2025Q4: 486,856 shares; 2026Q1: 486,856 shares; 2026Q2: 308,856 shares; 2026Q3: 502,372 shares 502,372$15.9M3.16%+193,516Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 14,096 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares; 2026Q2: 310,000 shares; 2026Q3: 400,000 shares 400,000$12.9M2.56%+90,000Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: 175,000 shares; 2025Q2: 110,000 shares; 2025Q3: 110,000 shares; 2025Q4: 515,000 shares; 2026Q1: 515,000 shares; 2026Q2: 407,338 shares; 2026Q3: 482,338 shares 482,338$12.3M2.44%+75,000Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,035,528 shares; 2025Q3: 11,280 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 370,084 shares; 2026Q3: 370,084 shares 370,084$11.9M2.35%0Timeline
ANIPANI PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 147,085 shares; 2026Q2: 272,085 shares; 2026Q3: 149,065 shares 149,065$10.8M2.15%-123,020Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 394,538 shares; 2025Q1: 289,538 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 126,541 shares; 2026Q3: 232,055 shares 232,055$10.6M2.11%+105,514Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 322,740 shares; 2025Q2: 262,740 shares; 2025Q3: 740,825 shares; 2025Q4: 644,680 shares; 2026Q1: 378,999 shares; 2026Q2: 378,999 shares; 2026Q3: 301,402 shares 301,402$8.19M1.63%-77,597Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 282,874 shares; 2026Q1: 807,874 shares; 2026Q2: 807,874 shares; 2026Q3: 594,666 shares 594,666$7.98M1.58%-213,208Timeline
CUECUE BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 104,364 shares; 2026Q3: 290,633 shares 290,633$7.52M1.49%+186,269Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 610,000 shares; 2026Q1: 1,214,741 shares; 2026Q2: 809,741 shares; 2026Q3: 809,741 shares 809,741$7.37M1.46%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 142,328 shares; 2025Q1: 269,090 shares; 2025Q2: 163,696 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 157,537 shares; 2026Q2: 205,837 shares; 2026Q3: 306,338 shares 306,338$7.13M1.42%+100,501Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 522,765 shares 522,765$7.04M1.4%newTimeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,908 shares; 2025Q1: 5,908 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 47,861 shares; 2026Q3: 86,761 shares 86,761$6.91M1.37%+38,900Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,433,000 shares; 2026Q3: 1,933,000 shares 1,933,000$6.44M1.28%-500,000Timeline
ACOGALPHA COGNITION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 755,867 shares; 2025Q1: 967,867 shares; 2025Q2: 917,867 shares; 2025Q3: 946,259 shares; 2025Q4: 1,056,259 shares; 2026Q1: 1,056,259 shares; 2026Q2: 836,259 shares; 2026Q3: 701,259 shares 701,259$6.31M1.25%-135,000Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 60,000 shares; 2026Q3: 285,000 shares 285,000$6.13M1.22%+225,000Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 300,000 shares; 2026Q1: 512,349 shares; 2026Q2: 427,349 shares; 2026Q3: 427,349 shares 427,349$6M1.19%0Timeline
HELPCYBIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 397,175 shares; 2025Q1: 397,175 shares; 2025Q2: 140,475 shares; 2025Q3: 140,475 shares; 2025Q4: 132,153 shares; 2026Q1: 132,153 shares; 2026Q2: 132,153 shares; 2026Q3: 487,575 shares 487,575$5.99M1.19%+355,422Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,497 shares; 2025Q3: 22,497 shares; 2025Q4: 21,351 shares; 2026Q1: 6,351 shares; 2026Q2: 35,386 shares; 2026Q3: 199,694 shares 199,694$5.94M1.18%+164,308Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 275,710 shares 275,710$5.87M1.16%newTimeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 362,626 shares 362,626$5.71M1.13%newTimeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 868,069 shares; 2025Q3: 892,229 shares; 2025Q4: 1,492,229 shares; 2026Q1: 1,492,229 shares; 2026Q2: 3,425,930 shares; 2026Q3: 3,425,930 shares 3,425,930$5.69M1.13%0Timeline
CRDLCARDIOL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,725,000 shares; 2026Q2: 3,325,000 shares; 2026Q3: 3,325,000 shares 3,325,000$5.52M1.09%0Timeline
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40,270 shares; 2025Q1: 40,270 shares; 2025Q2: 40,270 shares; 2025Q3: 1,843,060 shares; 2025Q4: 3,068,359 shares; 2026Q1: 2,688,359 shares; 2026Q2: 2,148,359 shares; 2026Q3: 1,448,359 shares 1,448,359$5.46M1.08%-700,000Timeline
PTHSPELTHOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 62,451 shares; 2025Q4: 255,758 shares; 2026Q1: 256,598 shares; 2026Q2: 256,598 shares; 2026Q3: 256,598 shares 256,598$5.39M1.07%0Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,095,574 shares; 2025Q4: 247,558 shares; 2026Q1: 2,894,704 shares; 2026Q2: 2,269,704 shares; 2026Q3: 2,119,704 shares 2,119,704$5.28M1.05%-150,000Timeline
SPRBSPRUCE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 13,332 shares; 2025Q4: 121,356 shares; 2026Q1: 121,356 shares; 2026Q2: 121,356 shares; 2026Q3: 101,356 shares 101,356$4.92M0.98%-20,000Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$4.77M0.95%newTimeline
VOGXVOGENX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 208,836 shares 208,836$4.76M0.94%newTimeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 469,949 shares; 2025Q1: 494,949 shares; 2025Q2: 469,949 shares; 2025Q3: 245,518 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 425,000 shares; 2026Q3: 225,000 shares 225,000$4.63M0.92%-200,000Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 152,211 shares; 2025Q1: 65,431 shares; 2025Q2: 65,431 shares; 2025Q3: 15,431 shares; 2025Q4: 159,421 shares; 2026Q1: 166,647 shares; 2026Q2: 88,951 shares; 2026Q3: 88,951 shares 88,951$4.43M0.88%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,132,322 shares; 2025Q4: 802,322 shares; 2026Q1: 1,193,492 shares; 2026Q2: 1,218,492 shares; 2026Q3: 1,018,492 shares 1,018,492$4.24M0.84%-200,000Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 502,601 shares; 2026Q1: 1,429,101 shares; 2026Q2: 1,129,101 shares; 2026Q3: 1,129,101 shares 1,129,101$4.22M0.84%0Timeline
CPIXCUMBERLAND PHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 740,000 shares; 2025Q2: 595,932 shares; 2025Q3: 555,932 shares; 2025Q4: 555,932 shares; 2026Q1: 553,153 shares; 2026Q2: 503,153 shares; 2026Q3: 503,153 shares 503,153$3.94M0.78%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,047 shares 100,047$3.91M0.78%newTimeline
RZLTREZOLUTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 857,230 shares; 2025Q1: 50,058 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,479 shares; 2026Q1: 16,479 shares; 2026Q2: 935,012 shares; 2026Q3: 935,012 shares 935,012$3.87M0.77%0Timeline
AMANAMANAT ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 349,836 shares 349,836$3.73M0.74%+199,836Timeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 912,906 shares 912,906$3.69M0.73%newTimeline
OCGNOCUGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,962,972 shares; 2026Q2: 3,962,972 shares; 2026Q3: 3,562,972 shares 3,562,972$3.67M0.73%-400,000Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 950,000 shares; 2025Q1: 950,000 shares; 2025Q2: 900,000 shares; 2025Q3: 760,000 shares; 2025Q4: 2,082,606 shares; 2026Q1: 2,082,606 shares; 2026Q2: 1,982,606 shares; 2026Q3: 1,982,606 shares 1,982,606$3.67M0.73%0Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 91,994 shares; 2025Q1: 191,994 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 758,654 shares; 2026Q1: 598,281 shares; 2026Q2: 383,281 shares; 2026Q3: 383,281 shares 383,281$3.31M0.66%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 873,568 shares; 2025Q3: 900,784 shares; 2025Q4: 865,784 shares; 2026Q1: 865,784 shares; 2026Q2: 830,784 shares; 2026Q3: 821,790 shares 821,790$3.29M0.65%-8,994Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 58,300 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000$3.21M0.64%newTimeline
IRLAQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 72,251 shares; 2026Q3: 95,652 shares 95,652$2.97M0.59%+23,401Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 430,000 shares; 2026Q3: 345,000 shares 345,000$2.85M0.57%-85,000Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 229,900 shares; 2025Q2: 850,000 shares; 2025Q3: 226,257 shares; 2025Q4: 358,257 shares; 2026Q1: 358,257 shares; 2026Q2: 358,257 shares; 2026Q3: 358,257 shares 358,257$2.77M0.55%0Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,788,486 shares; 2026Q1: 5,388,486 shares; 2026Q2: 4,538,534 shares; 2026Q3: 2,235,534 shares 2,235,534$2.46M0.49%-2,303,000Timeline
RNTXREIN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,950,000 shares; 2026Q3: 2,950,000 shares 2,950,000$2.37M0.47%0Timeline
KZIAKAZIA THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 396,201 shares; 2026Q3: 246,201 shares 246,201$2.36M0.47%-150,000Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 265,769 shares; 2025Q1: 265,769 shares; 2025Q2: 265,769 shares; 2025Q3: 265,769 shares; 2025Q4: 254,312 shares; 2026Q1: 1,053,797 shares; 2026Q2: 1,053,797 shares; 2026Q3: 1,053,797 shares 1,053,797$2.34M0.46%0Timeline
IVVDINVIVYD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,078,706 shares; 2025Q4: 2,656,570 shares; 2026Q1: 2,656,570 shares; 2026Q2: 2,656,570 shares; 2026Q3: 2,656,570 shares 2,656,570$2.31M0.46%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 28,099 shares; 2026Q2: 28,099 shares; 2026Q3: 112,000 shares 112,000$2.26M0.45%+83,901Timeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 55,000 shares; 2026Q2: 205,000 shares; 2026Q3: 205,000 shares 205,000$2.22M0.44%0Timeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 150,061 shares 150,061$2.19M0.43%newTimeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 158,942 shares 158,942$2.18M0.43%newTimeline
CAPRCAPRICOR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 264,642 shares; 2025Q4: 578,015 shares; 2026Q1: 528,015 shares; 2026Q2: 604,215 shares; 2026Q3: 229,215 shares 229,215$2.17M0.43%-375,000Timeline
DCTHDELCATH SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,365 shares; 2025Q1: 100,365 shares; 2025Q2: 322,390 shares; 2025Q3: 431,251 shares; 2025Q4: 431,251 shares; 2026Q1: 431,251 shares; 2026Q2: 185,667 shares; 2026Q3: 135,667 shares 135,667$2.17M0.43%-50,000Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 150,037 shares 150,037$2.15M0.43%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 145,502 shares; 2025Q2: 276,950 shares; 2025Q3: 28,571 shares; 2025Q4: 86,581 shares; 2026Q1: 71,581 shares; 2026Q2: 72,842 shares; 2026Q3: 6,942 shares 6,942$2.02M0.4%-65,900Timeline
STIMNEURONETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,100,000 shares; 2025Q2: 1,099,700 shares; 2025Q3: 905,716 shares; 2025Q4: 701,182 shares; 2026Q1: 701,182 shares; 2026Q2: 701,182 shares; 2026Q3: 810,182 shares 810,182$1.9M0.38%+109,000Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 212,481 shares; 2026Q1: 412,481 shares; 2026Q2: 748,181 shares; 2026Q3: 133,181 shares 133,181$1.78M0.35%-615,000Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 499,301 shares; 2025Q1: 550,029 shares; 2025Q2: 550,029 shares; 2025Q3: 567,601 shares; 2025Q4: 513,011 shares; 2026Q1: 513,011 shares; 2026Q2: 513,011 shares; 2026Q3: 513,011 shares 513,011$1.73M0.34%0Timeline
VSTMVERASTEM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 213,865 shares; 2026Q1: 213,865 shares; 2026Q2: 213,865 shares; 2026Q3: 213,865 shares 213,865$1.72M0.34%0Timeline
DERMJOURNEY MED CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 251,436 shares; 2026Q1: 251,436 shares; 2026Q2: 251,436 shares; 2026Q3: 251,436 shares 251,436$1.72M0.34%0Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 67,464 shares; 2026Q3: 182,464 shares 182,464$1.7M0.34%+115,000Timeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares; 2025Q3: 535,967 shares; 2025Q4: 447,165 shares; 2026Q1: 447,165 shares; 2026Q2: 447,165 shares; 2026Q3: 693,539 shares 693,539$1.68M0.33%+246,374Timeline
FULCFULCRUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,096 shares; 2025Q1: 200,096 shares; 2025Q2: 428,521 shares; 2025Q3: 1,289,225 shares; 2025Q4: 1,375,472 shares; 2026Q1: 1,049,161 shares; 2026Q2: 1,049,161 shares; 2026Q3: 449,161 shares 449,161$1.66M0.33%-600,000Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 60,000 shares; 2025Q1: 35,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 65,000 shares 65,000$1.42M0.28%newTimeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 970,259 shares; 2025Q1: 200,000 shares; 2025Q2: 35,300 shares; 2025Q3: 159,777 shares; 2025Q4: 31,106 shares; 2026Q1: not reported; 2026Q2: 90,183 shares; 2026Q3: 90,183 shares 90,183$1.38M0.27%0Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 900,000 shares; 2026Q1: 900,000 shares; 2026Q2: 700,000 shares; 2026Q3: 700,000 shares 700,000$1.34M0.27%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 607,689 shares; 2025Q1: 485,021 shares; 2025Q2: 196,536 shares; 2025Q3: 73,619 shares; 2025Q4: 31,166 shares; 2026Q1: 31,166 shares; 2026Q2: 31,166 shares; 2026Q3: 16,858 shares 16,858$1.33M0.26%-14,308Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 119,986 shares; 2025Q3: 58,610 shares; 2025Q4: 91,060 shares; 2026Q1: 91,060 shares; 2026Q2: not reported; 2026Q3: 49,800 shares 49,800$1.2M0.24%newTimeline
PTNPALATIN TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 130,000 shares 130,000$1.15M0.23%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 599,913 shares; 2025Q1: 599,913 shares; 2025Q2: 599,913 shares; 2025Q3: 617,327 shares; 2025Q4: 957,062 shares; 2026Q1: 957,062 shares; 2026Q2: 957,062 shares; 2026Q3: 957,062 shares 957,062$1.13M0.22%0Timeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 199,542 shares; 2026Q1: 508,556 shares; 2026Q2: 508,556 shares; 2026Q3: 508,556 shares 508,556$1.12M0.22%0Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$1.08M0.21%0Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 525,000 shares; 2026Q1: 525,000 shares; 2026Q2: 525,000 shares; 2026Q3: 453,374 shares 453,374$1.07M0.21%-71,626Timeline
HROWHARROW INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 183,347 shares; 2026Q1: 543,047 shares; 2026Q2: 135,775 shares; 2026Q3: 33,275 shares 33,275$1.02M0.2%-102,500Timeline
QNRXQUOIN PHARMACEUTICALS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 211,538 shares; 2026Q1: 211,538 shares; 2026Q2: 211,538 shares; 2026Q3: 211,538 shares 211,538$965K0.19%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 55,107 shares; 2025Q1: 25,107 shares; 2025Q2: 25,107 shares; 2025Q3: 25,107 shares; 2025Q4: 24,093 shares; 2026Q1: 24,093 shares; 2026Q2: 24,093 shares; 2026Q3: 1,342,626 shares 1,342,626$779K0.15%+1,318,533Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 15,457 shares; 2025Q2: 12,498 shares; 2025Q3: 12,498 shares; 2025Q4: 1,278,408 shares; 2026Q1: 1,278,408 shares; 2026Q2: 1,278,408 shares; 2026Q3: 1,278,408 shares 1,278,408$762K0.15%0Timeline
CNSPCNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,830 shares; 2026Q1: 45,830 shares; 2026Q2: 135,830 shares; 2026Q3: 135,830 shares 135,830$720K0.14%0Timeline
KLRSKALARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 360,000 shares; 2026Q1: 360,000 shares; 2026Q2: 360,000 shares; 2026Q3: 248,257 shares 248,257$717K0.14%-111,743Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 205,056 shares 205,056$671K0.13%newTimeline
AEONAEON BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,203,406 shares 2,203,406$661K0.13%newTimeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$626K0.12%newTimeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,800,000 shares; 2025Q4: 1,100,000 shares; 2026Q1: 1,100,000 shares; 2026Q2: 1,100,000 shares; 2026Q3: 1,100,000 shares 1,100,000$599K0.12%0Timeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 160,000 shares 160,000$571K0.11%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 33,899 shares; 2026Q2: 33,899 shares; 2026Q3: 33,899 shares 33,899$542K0.11%0Timeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 274,978 shares; 2026Q1: 274,978 shares; 2026Q2: 750,000 shares; 2026Q3: 400,000 shares 400,000$540K0.11%-350,000Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 332,297 shares; 2025Q4: 303,555 shares; 2026Q1: 303,555 shares; 2026Q2: 303,555 shares; 2026Q3: 303,555 shares 303,555$493K0.1%0Timeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 85,300 shares 85,300$449K0.09%newTimeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 49,396 shares; 2025Q3: 49,396 shares; 2025Q4: 48,569 shares; 2026Q1: 48,569 shares; 2026Q2: 48,569 shares; 2026Q3: 48,569 shares 48,569$426K0.08%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 43,799 shares; 2025Q3: 43,799 shares; 2025Q4: 41,081 shares; 2026Q1: 41,081 shares; 2026Q2: 41,081 shares; 2026Q3: 41,081 shares 41,081$402K0.08%0Timeline
AVRANTERIS TECHNOLOGIES GLOBALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 366,571 shares; 2026Q2: 166,571 shares; 2026Q3: 50,862 shares 50,862$395K0.08%-115,709Timeline
PURRHYPERLIQUID STRATEGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,001 shares; 2026Q1: 30,001 shares; 2026Q2: 30,001 shares; 2026Q3: 30,001 shares 30,001$368K0.07%0Timeline
VKTXVIKING THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 50,000 shares; 2025Q2: 100,000 shares; 2025Q3: 10,000 shares; 2025Q4: 9,717 shares; 2026Q1: 9,717 shares; 2026Q2: 9,717 shares; 2026Q3: 9,717 shares 9,717$317K0.06%0Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 230,000 shares; 2025Q2: not reported; 2025Q3: 176,690 shares; 2025Q4: 160,409 shares; 2026Q1: 264,409 shares; 2026Q2: 42,956 shares; 2026Q3: 42,956 shares 42,956$311K0.06%0Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,550,000 shares; 2025Q1: 1,417,952 shares; 2025Q2: 176,479 shares; 2025Q3: 176,479 shares; 2025Q4: 164,674 shares; 2026Q1: 164,674 shares; 2026Q2: 164,674 shares; 2026Q3: 164,674 shares 164,674$309K0.06%0Timeline
ALMSALUMIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,213,548 shares; 2026Q2: 870,548 shares; 2026Q3: 41,177 shares 41,177$304K0.06%-829,371Timeline
MGNXMACROGENICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 80,071 shares; 2025Q1: 80,071 shares; 2025Q2: 80,071 shares; 2025Q3: 80,071 shares; 2025Q4: 74,893 shares; 2026Q1: 74,893 shares; 2026Q2: 74,893 shares; 2026Q3: 74,893 shares 74,893$289K0.06%0Timeline
TRAWTRAWS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 98,493 shares; 2025Q1: 28,493 shares; 2025Q2: 28,493 shares; 2025Q3: 28,493 shares; 2025Q4: 678,142 shares; 2026Q1: 678,142 shares; 2026Q2: 478,142 shares; 2026Q3: 478,142 shares 478,142$284K0.06%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 967,600 shares; 2025Q4: 967,600 shares; 2026Q1: 1,017,600 shares; 2026Q2: 787,600 shares; 2026Q3: 136,648 shares 136,648$258K0.05%-650,952Timeline
EVAXEVAXION ASQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 80,000 shares; 2025Q2: 80,000 shares; 2025Q3: 80,000 shares; 2025Q4: 74,698 shares; 2026Q1: 74,698 shares; 2026Q2: 74,698 shares; 2026Q3: 74,698 shares 74,698$245K0.05%0Timeline
INMINMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 245,025 shares; 2026Q3: 137,634 shares 137,634$187K0.04%-107,391Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 202,894 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 400,000 shares; 2026Q1: 675,000 shares; 2026Q2: 15,000 shares; 2026Q3: 15,000 shares 15,000$187K0.04%0Timeline
NEUPNEUPHORIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 47,443 shares; 2026Q1: 47,443 shares; 2026Q2: 47,443 shares; 2026Q3: 47,443 shares 47,443$169K0.03%0Timeline
VTGNVISTAGEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 77,616 shares; 2025Q1: 601,703 shares; 2025Q2: 601,703 shares; 2025Q3: 620,869 shares; 2025Q4: 519,077 shares; 2026Q1: 519,077 shares; 2026Q2: 519,077 shares; 2026Q3: 519,077 shares 519,077$160K0.03%0Timeline
RNACCARTESIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 52,166 shares; 2025Q1: 22,166 shares; 2025Q2: 22,166 shares; 2025Q3: 22,166 shares; 2025Q4: 20,807 shares; 2026Q1: 20,807 shares; 2026Q2: 20,807 shares; 2026Q3: 20,807 shares 20,807$150K0.03%0Timeline
PMVPPMV PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 97,500 shares; 2025Q4: 89,136 shares; 2026Q1: 89,136 shares; 2026Q2: 89,136 shares; 2026Q3: 89,136 shares 89,136$149K0.03%0Timeline
ENVBENVERIC BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 100,002 shares; 2026Q3: 100,002 shares 100,002$147K0.03%0Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 55,766 shares; 2025Q1: 55,766 shares; 2025Q2: 55,766 shares; 2025Q3: 55,766 shares; 2025Q4: 53,063 shares; 2026Q1: 53,063 shares; 2026Q2: 53,063 shares; 2026Q3: 53,063 shares 53,063$142K0.03%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 16,756 shares; 2026Q3: 16,756 shares 16,756$140K0.03%0Timeline
NYXHNYXOAH S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,627 shares; 2025Q3: 50,627 shares; 2025Q4: 47,358 shares; 2026Q1: 47,358 shares; 2026Q2: 47,358 shares; 2026Q3: 47,358 shares 47,358$65.4K0.01%0Timeline
CMMBCHEMOMAB THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 53,262 shares; 2025Q4: 51,793 shares; 2026Q1: 51,793 shares; 2026Q2: 51,793 shares; 2026Q3: 51,793 shares 51,793$61.6K0.01%0Timeline
MGRXMANGOCEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 138,146 shares; 2026Q1: 138,146 shares; 2026Q2: 138,146 shares; 2026Q3: 138,146 shares 138,146$59.1K0.01%0Timeline
AIRSAIRSCULPT TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 17,951 shares; 2025Q3: 17,951 shares; 2025Q4: 16,398 shares; 2026Q1: 16,398 shares; 2026Q2: 16,398 shares; 2026Q3: 16,398 shares 16,398$28.9K0.01%0Timeline
TOVXTHERIVA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 120,031 shares; 2025Q2: 120,031 shares; 2025Q3: 120,031 shares; 2025Q4: 112,076 shares; 2026Q1: 112,076 shares; 2026Q2: 112,076 shares; 2026Q3: 112,076 shares 112,076$25.2K0.01%0Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 800,000 shares; 2026Q1: 18,000 shares; 2026Q2: 18,000 shares; 2026Q3: 18,000 shares 18,000$18.7K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
MRNAMODERNA INC COMput400,000$77M0
BMYBRISTOL-MYERS SQUIBB CO COMput992,500$61.9M+950,000
XBISPDR SERIES TRUST S&P BIOTECHput300,000$47.3M0
PRAXPRAXIS PRECISION MEDICINES I COM NEWcall99,800$29.1M+79,800
IRONDISC MEDICINE INC Stockput389,100$25.5M+375,800
INCYINCYTE CORP Stockput150,000$18.2Mnew
ACADACADIA PHARMACEUTICALS INC COMcall850,000$17.1Mnew
PCVXVAXCYTE INC Stockput300,000$17.1Mnew
KYMRKYMERA THERAPEUTICS INC COMput133,100$14.9M+82,700
KODKODIAK SCIENCES INC COMcall149,600$14.2M-68,100
IRONDISC MEDICINE INC Stockcall200,000$13.1M+186,700
SMMTSUMMIT THERAPEUTICS INC COMcall650,000$11Mnew
RAPPRAPPORT THERAPEUTICS INC Stockput316,400$10.6Mnew
ABVXABIVAX SA SPONSORED ADScall100,000$9.9M-241,100
NAMSNEWAMSTERDAM PHARMA COMPANY COMMON STOCKput400,000$9.73Mnew
NAMSNEWAMSTERDAM PHARMA COMPANY COMMON STOCKcall400,000$9.73Mnew
CLDXCELLDEX THERAPEUTICS INC NEW COM NEWput251,500$8.15M+137,500
ACADACADIA PHARMACEUTICALS INC COMput350,000$7.05Mnew
QUREUNIQURE NV SHScall267,000$6.45Mnew
HELPCYBIN INC COM NEWcall500,000$6.14Mnew
RAPPRAPPORT THERAPEUTICS INC Stockcall166,400$5.59Mnew
SEPNSEPTERNA INC Stockcall127,200$4.98Mnew
DYNDYNE THERAPEUTICS INC Stockput300,000$4.83Mnew
CBIOCRESCENT BIOPHARMA INC. COMMON STOCKcall300,000$4.38Mnew
SLSSELLAS LIFE SCIENCES GROUP I COM NEWput354,700$4.37M0
SRZNSURROZEN INC COMMON STOCKput134,000$4.31Mnew
ORICORIC PHARMACEUTICALS INC COMcall300,000$4.04Mnew
CTNMCONTINEUM THERAPEUTICS INC Stockcall300,000$4.03Mnew
SEPNSEPTERNA INC Stockput95,200$3.73Mnew
BCAXBICARA THERAPEUTICS INC COMcall200,000$3.72Mnew
ERASERASCA INC Stockput250,000$3.67Mnew
ERASERASCA INC Stockcall250,000$3.67Mnew
SRZNSURROZEN INC COMMON STOCKcall100,000$3.22Mnew
AVIRATEA PHARMACEUTICALS INC COMMON STOCKcall614,500$3.2Mnew
ALMSALUMIS INC COMcall356,300$2.63M0
AVTXAVALO THERAPEUTICS INC COMMON STOCKcall142,500$2.18Mnew
OLMAOLEMA PHARMACEUTICALS INC COMcall250,000$2.16M+50,000
XNCRXENCOR INC COMMON STOCKput84,700$2.11Mnew
XNCRXENCOR INC COMMON STOCKcall84,700$2.11Mnew
CCCCC4 THERAPEUTICS INC COM STKcall500,000$1.67Mnew
VERAVERA THERAPEUTICS INC COMMON STOCKcall50,000$1.61M-21,700
IVAINVENTIVA SA ADScall315,600$1.16Mnew
EYPTEYEPOINT INC Stockput220,400$721K-150,000
TENXTENAX THERAPEUTICS INC COM NEWcall356,600$674K-16,500
SIONSIONNA THERAPEUTICS INC COMMON STOCKput85,300$449K-22,200
RAREULTRAGENYX PHARMACEUTICAL IN COMcall28,700$431Knew
SIONSIONNA THERAPEUTICS INC COMMON STOCKcall50,000$263Knew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ABVXABIVAX SA250,000$33.3Mput
IONSIONIS PHARMACEUTICALS INC400,000$31.7Mcall
IONSIONIS PHARMACEUTICALS INC300,000$23.8Mput
NEWAMSTERDAM PHARMA COMPANYNEWAMSTERDAM PHARMA COMPANY400,000$13.6Mput
DMRADAMORA THERAPEUTICS INC335,710$8.73Mshares
CAPRCAPRICOR THERAPEUTICS INC350,000$8.43Mcall
ARWRARROWHEAD PHARMACEUTICALS IN100,000$8.15Mput
HIMSHIMS & HERS HEALTH INC188,381$6.53Mshares
RAREULTRAGENYX PHARMACEUTICAL IN165,617$5.53Mshares
EYPTEYEPOINT INC370,400$5.3Mcall
BIOABIOAGE LABS INC200,000$4.9Mshares
BBIOBRIDGEBIO PHARMA INC57,417$4.28Mshares
ABSIABSCI CORPORATION353,772$4.1Mshares
CLYMCLIMB BIO INC300,000$3.91Mshares
ARWRARROWHEAD PHARMACEUTICALS IN38,278$3.12Mshares
QTTBQ32 BIO INC200,000$2.55Mput
ANNXANNEXON INC430,244$2.46Mshares
UNIQURE NVUNIQURE NV49,800$2.29Mcall
TRAXFIRST TRACKS BIOTHERAPEUTICS42,775$861Kshares
LABDDIREXION SHARES ETF TRUST105,822$816Kshares
WVEWAVE LIFE SCIENCES LTD85,285$496Kshares
PASGPASSAGE BIO INC99,517$486Kshares
NXTCNEXTCURE INC288,303$461Kshares
FBRXFORTE BIOSCIENCES INC20,972$446Kshares
ELTXELICIO THERAPEUTICS INC107,100$419Kput
ELTXELICIO THERAPEUTICS INC107,100$419Kcall
ELTXELICIO THERAPEUTICS INC100,000$391Kshares
PRAXPRAXIS PRECISION MEDICINES I900$301Kput
TENXTENAX THERAPEUTICS INC16,500$240Kput
VYNEVYNE THERAPEUTICS INC264,912$172Kshares
GCTKGLUCOTRACK INC45,830$14.6Kshares
AEMDAETHLON MED INC14,364$11.8Kshares
PHGEBIOMX INC19,473$6.77Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002881 base2026-11-16